Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Biden Reveals Details on Cancer Moonshot Project

By Drug Discovery Trends Editor | January 19, 2016

Drop of Light/Shutterstock.comVice President Joe Biden revealed more details about the cancer “moonshot” project that President Obama discussed during his final State of the Union address.

The announcement posted on the publishing platform Medium explained the project’s goal would be to “accelerate efforts to progress towards a cure, and to unleash new discoveries and breakthroughs for other deadly diseases”.

The primary objective of Biden’s initiative will be to “break down silos,” writes Stat News.

Biden’s team will work to increase resources like better funding and provide targeted incentives for the public and private sectors to help combat the disease. Also, he plans on fostering better collaboration between cancer centers and technology firms to enable better sharing of medical data.

Another important part of Biden’s agenda is to ensure patients play an important role in this research, according to the announcement. He writes that feedback from the patient community will be important so patients and their families are treated as “partners in care” by allowing access to their own health data with the added opportunity of contributing to the research.

Biden started working on this “moonshot” in October 2015 after abstaining from another run at the White House. His goal for the remainder of his term is to seek a cure for cancer, after his oldest son Beau died from brain cancer last May.


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50